CHINA PHARMA HOLDINGS, INC. Taxes Payable, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Taxes Payable, Current of $377.37 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2026-08-14
- 2026-06-30: Taxes Payable, Current $377.37K.
- 2026-03-31: Taxes Payable, Current $370.17K.
- 2025-12-31: Taxes Payable, Current $351.90K.
- 2025-09-30: Taxes Payable, Current $691.68K.
| Period end | Taxes Payable, Current | Taxes Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $377.37K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $370.17K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $351.90K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $691.68K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $741.38K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $555.14K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $441.06K 10-K · filed 2026-04-01 | $595.48K 10-K · filed 2025-03-31 |
| 2024-09-30 | $399.21K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $335.49K 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $1.03M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.02M 10-Q · filed 2023-11-13 | |
| 2022-12-31 | $1.07M 10-K · filed 2024-04-01 | |
| 2013-12-31 | $0.00 10-K · filed 2014-03-20 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $690.78K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $514.25K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $2.43M 10-K · filed 2014-03-20 | |
| 2012-09-30 | $3.02M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $3.27M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $3.54M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $3.08M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $3.30M 10-Q/A · filed 2012-03-06 | |
| 2011-06-30 | $3.36M 10-Q/A · filed 2011-09-06 | |
| 2010-12-31 | $2.39M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |